The changing landscape of diabetes management is experiencing a remarkable shift, driven by innovative incretin-based therapies. At this time, semaglutide has secured considerable traction, but rival medications like https://saulygkw630265.aboutyoublog.com/52914064/the-future-of-diabetes-comparing-tirzepatide-semaglutide-retatrutide-and-cagrilintide